Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics.
Abdelrahman ElhakimMartin KnauthMohamed ElhakimUlrich BöhmerJohannes PatzeltPeter RadkePublished in: Advances in respiratory medicine (2022)
Pulmonary artery hemodynamics were assessed using a delivery catheter for fibrinolysis, which is reproducible for identifying PE at risk of adverse outcomes. The results matched the right heart catheter results in EKOS and Heparin arm of Ultima trial, thereby confirming the validity of this potential diagnostic tool to assess therapy effectiveness and thereby reduce additional procedure-related complications, hospital residency, and economics. These results stress the importance of having an interdisciplinary team involved in the management of PE to evaluate the quality of life of these patients and this protocol shortens ICU admission to 6 h.
Keyphrases
- pulmonary artery
- pulmonary embolism
- coronary artery
- pulmonary hypertension
- pulmonary arterial hypertension
- end stage renal disease
- randomized controlled trial
- ultrasound guided
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- inferior vena cava
- systematic review
- study protocol
- intensive care unit
- healthcare
- palliative care
- prognostic factors
- peritoneal dialysis
- risk factors
- mechanical ventilation
- phase ii
- growth factor
- patient reported outcomes
- bone marrow
- human health
- mesenchymal stem cells
- acute respiratory distress syndrome
- acute care